Zymeworks.
company
- Reports this week
- 4
- Active events
- 2
- Connections
- 38
What's happening
Active this week
Earlier this month
One to three months ago
-
Stock trading activity for multiple companies, including Ultragenyx, Casey’s General Stores, Plains All American Pipeline, Weyerhaeuser, Zymeworks, and Ciena, was reported on the Nasdaq exchange on September 3, 2026.Some support1 report
-
Zymeworks was listed on the electronic stock exchange, with data aggregated by MarketBeat.Some support2 reports
-
Both Zymeworks and Panbela Therapeutics are small-cap biopharma companies.Some support1 report
Gone quiet
No new reports in 90+ days-
CTIM-76 targets different indications than ZW191.Some support1 report
-
Both Zymeworks and Petros Pharmaceuticals are small-cap medical companies in the biotech sector focusing on men's health therapeutics in the US.Some support1 report
-
The FDA cleared the IND application for ZW251, a product of Zymeworks.Some support4 reports1 development inside
-
Zymeworks achieved FDA approval for its drug zanidatamab, while also announcing personnel and award news.Some support1 report
-
Zymeworks announced a decision from Vancouver.Some support4 reports
-
Genmab, Amgen, Immunocore, Merck, and Zymeworks are key players in the bispecific antibodies market.Some support2 reports
-
Zymeworks shares underperformed the S&P 500 on August 8, 2025.Some support1 report
-
Zymeworks management participated in investor conferences held in Boston on August 19, 2025.Some support2 reports
-
Benzinga provided stock analysis on Zymeworks on September 3, 2025.Some support1 report
No events began in the chosen period. Widen it, or reset.
Around Zymeworks this week
News at the entities that move Zymeworks most-
FDA StructuralForbes named Elizabeth Holmes one of the richest women, while Theranos claimed FDA approval for its Herpes test.Moves Zymeworks
-
Jazz Pharmaceuticals StructuralJazz Pharmaceuticals plans U.S. launch of Ziihera.Moves Zymeworks
-
Ireland StructuralIreland traded dual-use items and weapons to Israel.Moves Zymeworks
-
Truist Financial Mentioned togetherTruist Financial analysts dropped the target price for Deckers Outdoor on July 24, 2026.Moves Zymeworks
-
Johnson & Johnson StructuralAppLovin fears being in Alphabet's crosshairs, while Compass Pathways avoids Johnson & Johnson due to size.Moves Zymeworks
-
Nasdaq StructuralLyft is listed on Nasdaq, and Cantor Fitzgerald has cut its target price while MarketBeat reports on the stock.Moves Zymeworks
Connections
The 18 strongest of 38, analyzed from the reporting. The bars show how strongly a change on one side reaches the other.-
Johnson & Johnson Structural
Johnson & Johnson utilizes Zymeworks' proprietary technology platform for the development and production of clinical-stage antibodies.
-
Paul Moore Structural
Paul Moore holds the formal position of Chief Scientific Officer at Zymeworks.
-
Jazz Pharmaceuticals Structural
A and B maintain a strategic partnership where B commercializes its assets using A's global reach, with financial milestones tied to A's regulatory successes.
-
FDA Structural
FDA formally regulates Zymeworks, granting product approvals and clearing necessary applications.
-
OMERS Transactional
OMERS subscribed to a non-recourse note related to Zymeworks.
-
Nasdaq Structural
Zymeworks is a company publicly listed and trades on the Nasdaq stock exchange.
-
Mylan Operational
The evidence suggests a functional partnership where Zymeworks leverages market access provided by the entity currently operating under the Viatris umbrella, which is the operational successor to Mylan.
-
Ireland Structural
Zymeworks leverages Ireland's fiscal environment by utilizing its tax attributes.
Show all 18 connections
-
New York Shared context
Zymeworks management is observed attending conferences in New York.
-
Chicago Shared context
Zymeworks participates in scientific meetings held in Chicago.
-
New York Shared context
Zymeworks conducts business activities, including investor conferences and operations, within the geographic area of New York.
-
Vancouver Shared context
Zymeworks is based and conducts its operations in Vancouver, British Columbia.
-
Boston Shared context
Zymeworks holds investor meetings and participates in conferences within the city of Boston.
-
Truist Financial Mentioned together
Truist Financial raised its price target on Zymeworks, signaling market confidence in the company.
-
MarketBeat Mentioned together
MarketBeat aggregates data on Zymeworks as part of its function as a financial news hub.
-
company Shared context
Zymeworks is described as a company that manages licensed healthcare assets and develops biotherapeutics.
-
London Shared context
Zymeworks management is observed participating in conferences held in London.
-
Jason McCarthy Mentioned together
No relationship between Zymeworks and Jason McCarthy was observed in the provided evidence.
History
Events by the month they beganOctober 2026
1 eventSeptember 2026
2 eventsAugust 2026
1 eventShow 2 earlier months
July 2026
2 eventsJune 2026
10 events- Zymeworks and Cytokinetics are companies operating in the medical/biomedical sector.
- Mylan and Zymeworks are involved in a deal aimed at bolstering Zymeworks’ commercial portfolio, related to COPD therapy.
- Both Zymeworks and Petros Pharmaceuticals are small-cap medical companies in the biotech sector focusing on men's health therapeutics in the US.
- The FDA cleared the IND application for ZW251, a product of Zymeworks.
- Zymeworks achieved FDA approval for its drug zanidatamab, while also announcing personnel and award news.
- Zymeworks announced a decision from Vancouver.
- Genmab, Amgen, Immunocore, Merck, and Zymeworks are key players in the bispecific antibodies market.
- Zymeworks shares underperformed the S&P 500 on August 8, 2025.
- Zymeworks management participated in investor conferences held in Boston on August 19, 2025.
- Benzinga provided stock analysis on Zymeworks on September 3, 2025.